Junichiro Yuda
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Immunology top 10%
- Immune Cell Function and Interaction
- Galectins and Cancer Biology
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
- Oncology 18
- CAR-T cell therapy research 13
- Hematology 17
- Chronic Myeloid Leukemia Treatments 10
- Acute Myeloid Leukemia Research 6
- Multiple Myeloma Research and Treatments 5
- Co-authors
- Yosuke Minami (12 shared papers)Koichi Akashi (11 shared papers)Toshihiro Miyamoto (11 shared papers)Takahiro Shima (9 shared papers)Yoshikane Kikushige (7 shared papers)Hiromi Iwasaki (4 shared papers)Katsuto Takenaka (5 shared papers)Shin‐ichiro Takayanagi (1 shared paper)
- Journals
- Blood (10 papers)Journal of Clinical Oncology (4 papers)International Journal of Clinical Oncology (4 papers)International Journal of Hematology (3 papers)Cancer Science (3 papers)
- Partner nations
- JapanUnited StatesSpain
In The Last Decade
Junichiro Yuda
35 papers receiving 563 citations
Peers
Comparison fields: 5 of 52
- Hematology 180
- Immunology 289
- Oncology 268
- Genetics 63
- Pathology and Forensic Medicine 58
Countries citing papers authored by Junichiro Yuda
This map shows the geographic impact of Junichiro Yuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junichiro Yuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junichiro Yuda more than expected).
Fields of papers citing papers by Junichiro Yuda
This network shows the impact of papers produced by Junichiro Yuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junichiro Yuda. The network helps show where Junichiro Yuda may publish in the future.
Co-authors
The 25 scholars most cited alongside Junichiro Yuda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 211 | |
| 2 | 2020 | 83 | |
| 3 | 2022 | 60 | |
| 4 | 2021 | 51 | |
| 5 | 2014 | 19 | |
| 6 | 2022 | 18 | |
| 7 | 2018 | 17 | |
| 8 | 2023 | 12 | |
| 9 | 2017 | 12 | |
| 10 | 2024 | 10 | |
| 11 | 2023 | 9 | |
| 12 | 2014 | 8 | |
| 13 | 2022 | 6 | |
| 14 | 2012 | 5 | |
| 15 | 2024 | 5 | |
| 16 | 2022 | 4 | |
| 17 | 2022 | 4 | |
| 18 | 2024 | 3 | |
| 19 | 2023 | 3 | |
| 20 | 2012 | 3 |
About Junichiro Yuda
Junichiro Yuda is a scholar working on Oncology, Hematology, Molecular Biology, Genetics and Immunology, having authored 43 papers that have together received 566 indexed citations. Recurring topics across this work include CAR-T cell therapy research (13 papers), Chronic Lymphocytic Leukemia Research (12 papers), Chronic Myeloid Leukemia Treatments (10 papers), Lymphoma Diagnosis and Treatment (7 papers), Acute Myeloid Leukemia Research (6 papers), Galectins and Cancer Biology (5 papers), Multiple Myeloma Research and Treatments (5 papers) and Protein Degradation and Inhibitors (4 papers). The work is most often cited by research in Hematology (180 citations), Immunology (289 citations), Oncology (268 citations), Genetics (63 citations) and Pathology and Forensic Medicine (58 citations). Junichiro Yuda has collaborated with scholars based in Japan, United States and Spain. Frequent co-authors include Yosuke Minami, Koichi Akashi, Toshihiro Miyamoto, Takahiro Shima, Yoshikane Kikushige, Hiromi Iwasaki, Katsuto Takenaka, Shin‐ichiro Takayanagi, Ayano Yurino and Siamak Jabbarzadeh‐Tabrizi. Their work appears in journals such as Blood, Journal of Clinical Oncology, International Journal of Clinical Oncology, International Journal of Hematology and Cancer Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.